Can adjusting drug schedules improve both urinary and sexual outcomes in men with enlarged prostate?

NCT ID NCT07715448

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This clinical trial investigates whether different dosing schedules of tadalafil or tamsulosin, when combined with a 5-alpha reductase inhibitor, can better manage urinary symptoms and preserve sexual function in men with benign prostatic hyperplasia (BPH). The study includes 240 men aged 50 and older with moderate to severe symptoms and an enlarged prostate. Over 12 weeks, researchers will measure changes in urinary symptoms, erectile function, and ejaculatory function to find the optimal combination regimen.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tadalafil or tamsulosin combined with a 5-alpha reductase inhibitor (finasteride or dutasteride)
What this could lead to
If successful, this could identify the most effective dosing regimen to improve both urinary symptoms and sexual function in men with an enlarged prostate.
What could go wrong
This is a single-blind, 12-week study with 240 participants, so results may not apply to all men or longer-term use. Side effects from these drugs can include dizziness, low blood pressure, and sexual side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Ejaculatory Dysfunction erectile dysfunction Lower Urinary Tract Symptoms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beni-Suef University Hospital

    Banī Suwayf, Beni Suef Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.